日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Application of Machine Learning to Auto-Code Injury Data in the e-CHIRPP System: Development and Evaluation Study

机器学习在e-CHIRPP系统中自动编码损伤数据中的应用:开发与评估研究

Mukhi, Shamir N; McFaull, Steven R; Thompson, Wendy; Beattie, Tim

Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis

向美国食品药品监督管理局提交的随机、安慰剂对照试验中,重度抑郁症急性单药治疗的疗效:个体参与者数据分析

Stone, Marc B; Yaseen, Zimri S; Miller, Brian J; Richardville, Kyle; Kalaria, Shamir N; Kirsch, Irving

An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials

一种探索性机器学习方法,用于识别药物治疗暴食症试验中的安慰剂反应者

Goyal, Rahul K; Kalaria, Shamir N; McElroy, Susan L; Gopalakrishnan, Mathangi

Overview of Canada's Antimicrobial Resistance Network (AMRNet): A data-driven One Health approach to antimicrobial resistance surveillance

加拿大抗菌素耐药性监测网络(AMRNet)概述:以数据驱动的“同一健康”方法开展抗菌素耐药性监测

Rudnick, Wallis; Mukhi, Shamir N; Reid-Smith, Richard J; German, Greg J; Nichani, Anil; Mulvey, Michael R

Erratum for Kalaria et al., "A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients"

更正 Kalaria 等人的论文“采用群体药代动力学和药效学方法优化危重患者他唑巴坦的活性”

Kalaria, Shamir N; Gopalakrishnan, Mathangi; Heil, Emily L

A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients

采用群体药代动力学和药效学方法优化他唑巴坦在危重患者中的活性

Kalaria, Shamir N; Gopalakrishnan, Mathangi; Heil, Emily L

A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01)

一项基于实践的临床药代动力学研究,旨在指导接受连续静脉-静脉血液滤过治疗的危重患者左乙拉西坦的剂量(PADRE-01)

Kalaria, Shamir N; Armahizer, Michael; McCarthy, Paul; Badjatia, Neeraj; Gobburu, Jogarao V; Gopalakrishnan, Mathangi

An Innovative Disease-Drug-Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate

一种指导暴食症药物研发的创新疾病-药物-试验框架:以托吡酯为例

Kalaria, Shamir N; McElroy, Susan L; Gobburu, Jogarao; Gopalakrishnan, Mathangi

Influenza-like illness-related emergency department visits: Christmas and New Year holiday peaks and relationships with laboratory-confirmed respiratory virus detections, Edmonton, Alberta, 2004-2014

2004-2014年阿尔伯塔省埃德蒙顿市,与流感样疾病相关的急诊就诊:圣诞节和新年假期高峰期及与实验室确诊呼吸道病毒检测结果的关系

Martin, Leah J; Im, Cindy; Dong, Huiru; Lee, Bonita E; Talbot, James; Meurer, David P; Mukhi, Shamir N; Drews, Steven J; Yasui, Yutaka

Heart rate variability in critical care medicine: a systematic review

重症监护医学中的心率变异性:系统评价

Karmali, Shamir N; Sciusco, Alberto; May, Shaun M; Ackland, Gareth L